Native LDL-induced oxidative stress in human proximal tubular cells: multiple players involved
暂无分享,去创建一个
M. Ripoli | L. Gesualdo | E. Montemurno | C. Piccoli | R. Scrima | G. Quarato | N. Capitanio | L. Calabresi | P. Cirillo | A. D’Aprile | D. Boffoli | M. Gomaraschi
[1] João Wosniak,et al. Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. , 2008, Antioxidants & redox signaling.
[2] J. Sowers,et al. Redox control of renal function and hypertension. , 2008, Antioxidants & redox signaling.
[3] Y. Ho,et al. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. , 2008, Free radical biology & medicine.
[4] L. Fried. Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease. , 2008, Kidney international.
[5] Hyun Soon Lee,et al. Oxidized Low-Density Lipoprotein and Oxidative Stress in the Development of Glomerulosclerosis , 2008, American Journal of Nephrology.
[6] M. Mattson,et al. Superoxide Flashes in Single Mitochondria , 2008, Cell.
[7] P. Pinton,et al. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. , 2008, Biochimica et biophysica acta.
[8] H. Sumimoto. Structure, regulation and evolution of Nox‐family NADPH oxidases that produce reactive oxygen species , 2008, The FEBS journal.
[9] Michael S Janes,et al. The selective detection of mitochondrial superoxide by live cell imaging , 2008, Nature Protocols.
[10] C. Winterbourn,et al. Reconciling the chemistry and biology of reactive oxygen species. , 2008, Nature chemical biology.
[11] A. Fogo. Mechanisms of progression of chronic kidney disease , 2007, Pediatric Nephrology.
[12] A. Fisher,et al. Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. , 2007, Molecular biology of the cell.
[13] H. Ginsberg,et al. Lipoprotein metabolism in chronic renal insufficiency , 2007, Pediatric Nephrology.
[14] M. Runge,et al. Mitochondrial Dysfunction in Atherosclerosis , 2007, Circulation research.
[15] K. Homma,et al. Ca2+ channel subtypes and pharmacology in the kidney. , 2007, Circulation research.
[16] KoichiroHomma,et al. Ca2+ Channel Subtypes and Pharmacology in the Kidney , 2007 .
[17] Yi-Jun Wu,et al. Characteristics of lysophosphatidylcholine-induced Ca2+ response in human neuroblastoma SH-SY5Y cells. , 2007, Life sciences.
[18] C. Chinopoulos,et al. Bioenergetics and the formation of mitochondrial reactive oxygen species. , 2006, Trends in pharmacological sciences.
[19] R. Levy. The role of cytosolic phospholipase A2-alfa in regulation of phagocytic functions. , 2006, Biochimica et biophysica acta.
[20] C. Wilcox,et al. NADPH oxidases in the kidney. , 2006, Antioxidants & redox signaling.
[21] H. Westerhoff,et al. A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. , 2006, Antioxidants & redox signaling.
[22] Mason W Freeman,et al. Scavenger receptors in atherosclerosis: beyond lipid uptake. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[23] J. Douglas,et al. Oxidative signaling in renal epithelium: Critical role of cytosolic phospholipase A2 and p38(SAPK). , 2006, Free radical biology & medicine.
[24] Simon J. Walker,et al. NADPH oxidases in cardiovascular health and disease. , 2006, Antioxidants & redox signaling.
[25] T. Kodama,et al. Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. , 2006, The American journal of pathology.
[26] S. Sollott,et al. Mitochondrial ROS-induced ROS release: an update and review. , 2006, Biochimica et biophysica acta.
[27] I. Fearon. OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production. , 2006, Cardiovascular research.
[28] M. Lorusso,et al. Arachidonic acid induces specific membrane permeability increase in heart mitochondria , 2006, FEBS letters.
[29] A. Cases,et al. Dyslipidemia and the progression of renal disease in chronic renal failure patients. , 2005, Kidney international. Supplement.
[30] D. Wallace. A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.
[31] P. Waring,et al. Redox active calcium ion channels and cell death. , 2005, Archives of biochemistry and biophysics.
[32] E. N. Wardle. Cellular Oxidative Processes in Relation to Renal Disease , 2005, American Journal of Nephrology.
[33] Tetsuhiro Tanaka,et al. Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells. , 2004, Journal of the American Society of Nephrology : JASN.
[34] Takao Shimizu,et al. Regulatory mechanism and physiological role of cytosolic phospholipase A2. , 2004, Biological & pharmaceutical bulletin.
[35] M. Prato,et al. Arachidonic Acid Released by Phospholipase A2 Activation Triggers Ca2+-dependent Apoptosis through the Mitochondrial Pathway* , 2004, Journal of Biological Chemistry.
[36] P. Fauré,et al. Cell culture media are potent antioxidants that interfere during LDL oxidation experiments. , 2004, Biochimie.
[37] M. Kretzler,et al. Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. , 2004, The American journal of pathology.
[38] R. Zager,et al. Proximal tubular cholesterol loading after mitochondrial, but not glycolytic, blockade. , 2003, American journal of physiology. Renal physiology.
[39] R. Levy,et al. The requirement of cytosolic phospholipase A2 for the PMA activation of proton efflux through the N-terminal 230-amino-acid fragment of gp91phox. , 2003, The Biochemical journal.
[40] R. Zager,et al. Acute tubular injury causes dysregulation of cellular cholesterol transport proteins. , 2003, The American journal of pathology.
[41] T. Finkel. Oxidant signals and oxidative stress. , 2003, Current opinion in cell biology.
[42] A A Gerencsér AA,et al. Selective, high-resolution fluorescence imaging of mitochondrial Ca2+ concentration. , 2001, Cell calcium.
[43] D. Harris,et al. Tubular‐interstitial interactions in proteinuric renal diseases , 2001 .
[44] A. Rittenhouse,et al. Arachidonic acid both inhibits and enhances whole cell calcium currents in rat sympathetic neurons. , 2001, American journal of physiology. Cell physiology.
[45] A E Vercesi,et al. Mitochondrial permeability transition and oxidative stress , 2001, FEBS letters.
[46] Steven J. Sollott,et al. Reactive Oxygen Species (Ros-Induced) Ros Release , 2000, The Journal of experimental medicine.
[47] L. Blatter,et al. Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. , 1999, The Biochemical journal.
[48] S. Papa,et al. Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. , 1999, Free radical biology & medicine.
[49] M. Trush,et al. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. , 1998, Biochemical and biophysical research communications.
[50] S. Lenzen,et al. Relation between accumulation of phospholipase A2 reaction products and Ca2+ release in isolated liver mitochondria. , 1996, Biochimica et biophysica acta.
[51] J. Gaillard,et al. Electron transfer across the O2- generating flavocytochrome b of neutrophils. Evidence for a transition from a low-spin state to a high-spin state of the heme iron component. , 1996, Biochemistry.
[52] G. Brown,et al. Control of respiration and ATP synthesis in mammalian mitochondria and cells. , 1992, The Biochemical journal.
[53] R. P. Noble. Electrophoretic separation of plasma lipoproteins in agarose gel. , 1968, Journal of lipid research.
[54] Chao-Yung Wang,et al. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. , 2008, Trends in molecular medicine.
[55] Lorenzo Galluzzi,et al. Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.
[56] S. Sasaki,et al. Function of chloride channels in the kidney. , 2005, Annual review of physiology.
[57] J. Dordick,et al. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. , 2002, Endothelium : journal of endothelial cell research.
[58] D. Lichtenberg,et al. Continuous monitoring of intermediates and final products of oxidation of low density lipoprotein by means of UV-spectroscopy. , 1996, Free radical research.
[59] J. Berliner,et al. The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.
[60] T. Carew,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[61] B. Chance,et al. Reactive oxygen intermediates in biochemistry. , 1986, Annual review of biochemistry.
[62] W. Kannel,et al. Role of lipids and lipoprotein fractions in atherogenesis: the Framingham study. , 1981, Progress in lipid research.